福瑞股份(300049)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300049 福瑞股份

午间休市 05-17 11:30:00

{"stockData":{"symbol":"300049","market":"SZ","secType":"STK","nameCN":"福瑞股份","latestPrice":51.85,"timestamp":1715916810000,"preClose":51.67,"halted":0,"volume":1561200,"delay":0,"floatShares":234000000,"shares":263000000,"eps":0.4991,"marketStatus":"午间休市","marketStatusCode":3,"change":0.18,"latestTime":"05-17 11:30:00","open":51.71,"high":52.71,"low":51.07,"amount":81164100,"amplitude":0.0317,"askPrice":51.92,"askSize":3,"bidPrice":51.85,"bidSize":9,"shortable":0,"etf":0,"ttmEps":0.4991,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715922000000},"adr":0,"adjPreClose":51.67,"symbolType":"stock","openAndCloseTimeList":[[1715909400000,1715916600000],[1715922000000,1715929200000]],"highLimit":56.84,"lowLimit":46.5,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":263053100,"pbRate":8.68,"roa":"--","roe":"2.72%","epsLYR":0.3861,"committee":0.333333,"marketValue":13639000000,"floatMarketCap":12108000000,"peRate":103.886997,"changeRate":0.0035,"turnoverRate":0.0067,"status":0},"requestUrl":"/m/hq/s/300049/wiki","defaultTab":"wiki","newsList":[{"id":"2434066637","title":"福瑞股份(300049)4月30日股东户数1.45万户，较上期减少3.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434066637","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2434066637?lang=zh_cn&edition=full","pubTime":"2024-05-09 17:03","pubTimestamp":1715245387,"startTime":"0","endTime":"0","summary":"证券之星消息，近日福瑞股份披露，截至2024年4月30日公司股东户数为1.45万户，较3月31日减少486.0户，减幅为3.24%。在医疗器械行业个股中，福瑞股份股东户数低于行业平均水平，截至4月30日，医疗器械行业平均股东户数为2.09万户。从股价来看，2024年3月31日至2024年4月30日，福瑞股份区间涨幅为3.83%，在此期间股东户数减少486.0户，减幅为3.24%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050900030686.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434066879","title":"福瑞股份：公司子公司泰拉克里昂（深圳）正在积极引入产品及开拓相关产品的市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2434066879","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2434066879?lang=zh_cn&edition=full","pubTime":"2024-05-09 17:02","pubTimestamp":1715245325,"startTime":"0","endTime":"0","summary":"公司子公司泰拉克里昂（深圳）正在积极引入产品及开拓相关产品的市场。泰拉克里昂（深圳）医疗设备有限公司主要从事高强度聚焦超声设备业务。公司按照《深圳证券交易所创业板股票上市规则》及相关规定，在定期报告中披露相关子公司情况。截止2024年4月10日，公司股东人数为15,001户。公司参股公司Theraclion在AI+医疗方面有相关产品的开发与服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050900030555.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433241656","title":"非酒精性脂肪性肝炎(NASH)概念盘中拉升，福瑞股份涨6.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433241656","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433241656?lang=zh_cn&edition=full","pubTime":"2024-05-06 14:42","pubTimestamp":1714977749,"startTime":"0","endTime":"0","summary":"05月06日，非酒精性脂肪性肝炎(NASH)概念盘中拉升，截至14点42分，非酒精性脂肪性肝炎(NASH)概念整体指数上涨4.01%，报1120.540点。从个股上来看，该概念的成分股中，福瑞股份涨6.12%，微芯生物、诺泰生物2只股涨幅超过5%。从资金上来看，截止发稿，非酒精性脂肪性肝炎(NASH)概念主力净流入为1648.22万，其中诺泰生物受到资金热捧，主力净流入2273.74万；拉长时间线来看，该板块近20日主力资金净流入-2.62亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050614422987e85c45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050614422987e85c45&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432636141","title":"福瑞股份获信达证券买入评级，新药获批催生检测需求，业绩逐渐进入兑现期","url":"https://stock-news.laohu8.com/highlight/detail?id=2432636141","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2432636141?lang=zh_cn&edition=full","pubTime":"2024-05-04 09:14","pubTimestamp":1714785256,"startTime":"0","endTime":"0","summary":"2024年5月4日，福瑞股份获信达证券买入评级，近一个月福瑞股份获得1份研报关注。研报认为，核心产品增长明显，新药获批上市有望催生更多检测需求。2024年3月14日，Madrigal公司NASH新药resmetirom获批上市，我们认为FibroScan有望成为NASH诊断的入口，带来诊断需求的大幅增长。叠加NASH新药获批催化设备的需求放量，公司全年业绩有望超预期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405040914198b71e121&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405040914198b71e121&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432168359","title":"信达证券：给予福瑞股份买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2432168359","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2432168359?lang=zh_cn&edition=full","pubTime":"2024-05-04 09:02","pubTimestamp":1714784532,"startTime":"0","endTime":"0","summary":"信达证券股份有限公司唐爱金近期对福瑞股份进行研究并发布了研究报告《新药获批催生检测需求，业绩逐渐进入兑现期》，本报告对福瑞股份给出买入评级，当前股价为51.0元。叠加NASH新药获批催化设备的需求放量，公司全年业绩有望超预期。我们看好公司在肝病检测领域的发展前景，维持对公司的“买入”评级。最新盈利预测明细如下：该股最近90天内共有4家机构给出评级，买入评级4家；过去90天内机构目标均价为52.57。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050400004032.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430059212","title":"福瑞股份最新公告：一季度净利润4271.9万元 同比增长228.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430059212","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430059212?lang=zh_cn&edition=full","pubTime":"2024-04-28 20:10","pubTimestamp":1714306246,"startTime":"0","endTime":"0","summary":"福瑞股份公布第一季度报告，营业收入3.2亿元，同比增长33.35%，净利润4271.9万元，同比增长228.57%。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042800008891.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430058710","title":"福瑞股份(300049.SZ)发布一季度业绩，净利润4271.91万元 同比增加228.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430058710","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430058710?lang=zh_cn&edition=full","pubTime":"2024-04-28 19:11","pubTimestamp":1714302672,"startTime":"0","endTime":"0","summary":"智通财经APP讯，福瑞股份(300049.SZ)发布2024年一季度报告，报告期内公司实现营业收入3.23亿元，同比增加33.35%;归属于上市公司股东的净利润4271.91万元，同比增加228.57%;归属于上市公司股东的扣除非经常性损益的净利润4129.12万元，同比增加126.24%;基本每股收益0.1624元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1113612.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430035863","title":"图解福瑞股份年报：第四季度单季净利润同比减23.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430035863","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430035863?lang=zh_cn&edition=full","pubTime":"2024-04-28 16:53","pubTimestamp":1714294422,"startTime":"0","endTime":"0","summary":"证券之星消息，福瑞股份2023年年报显示，公司主营收入11.54亿元，同比上升14.37%；归母净利润1.02亿元，同比上升3.75%；扣非净利润9864.93万元，同比下降1.04%；其中2023年第四季度，公司单季度主营收入3.47亿元，同比上升19.68%；单季度归母净利润2839.97万元，同比下降23.51%；单季度扣非净利润1921.41万元，同比下降49.55%；负债率30.22%，投资收益253.38万元，财务费用-610.83万元，毛利率74.74%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042800004254.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429181182","title":"福瑞股份（300049）4月22日主力资金净买入2341.24万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429181182","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429181182?lang=zh_cn&edition=full","pubTime":"2024-04-23 09:14","pubTimestamp":1713834842,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年4月22日收盘，福瑞股份报收于48.59元，上涨3.91%，换手率2.99%，成交量6.9万手，成交额3.33亿元。近5日资金流向一览见下表：福瑞股份融资融券信息显示，融资方面，当日融资买入3080.11万元，融资偿还2823.34万元，融资净买入256.77万元。福瑞股份主营业务：肝病领域的药品生产与销售、诊断设备研发与销售以及提供肝纤维化诊断治疗产品和服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300015963.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2407531997","title":"福瑞股份(300049.SZ)拟授出300万股限制性股票 授予价为18.09元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2407531997","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2407531997?lang=zh_cn&edition=full","pubTime":"2024-01-31 20:24","pubTimestamp":1706703840,"startTime":"0","endTime":"0","summary":"福瑞股份(300049.SZ)披露2024年限制性股票激励计划(草案)，公司拟拟向激励对象授予300万股限制性股票，授予价格为18.09元/股。本激励计划的有效期为自限制性股票授予登记完成之日起至激励对象获授的限制性股票全部解除限售或回购注销之日止，最长不超过48个月。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-31/doc-inafmpkc5707852.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-31/doc-inafmpkc5707852.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2401534869","title":"福瑞股份(300049.SZ)发预增，预计2023年净利润0.98亿元至1.27亿元 增长0%–30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2401534869","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2401534869?lang=zh_cn&edition=full","pubTime":"2024-01-05 18:06","pubTimestamp":1704449160,"startTime":"0","endTime":"0","summary":"福瑞股份发布2023年度业绩预告，预计归属于上市公司股东的净利润0.98亿元至1.27亿元，同比增长0%–30%。业绩变动原因：1、2023年度，法国控股子公司医疗器械业务持续拓展，整体实现约1.8亿元-2亿元净利润，对归属于上市公司股东的净利润影响为0.9亿元-1亿元。其中，由于公司未达到2023年员工持股计划业绩考核目标，本年度转回股份支付费用对净利润的影响约2,200万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-05/doc-inaanncv4935058.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-05/doc-inaanncv4935058.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2010-01-20","address":"内蒙古自治区乌兰察布市集宁区解放路103号","stockEarnings":[{"period":"1week","weight":-0.0067},{"period":"1month","weight":0.1364},{"period":"3month","weight":0.389},{"period":"6month","weight":0.4014},{"period":"1year","weight":0.7909},{"period":"ytd","weight":0.1854}],"companyName":"内蒙古福瑞医疗科技股份有限公司","boardCode":"AI0035","perCapita":"16110股","boardName":"专用设备制造业","registeredCapital":"26305万元","compareEarnings":[{"period":"1week","weight":-0.0101},{"period":"1month","weight":0.0384},{"period":"3month","weight":0.0895},{"period":"6month","weight":0.0223},{"period":"1year","weight":-0.0493},{"period":"ytd","weight":0.0496}],"survey":"　　内蒙古福瑞医疗科技股份有限公司的主营业务为肝病领域的药品生产与销售、诊断设备研发与销售以及医疗服务相关业务,主要产品为复方鳖甲软肝片。2022年1月,公司凭借长期践行社会责任的行动和坚持公益的企业责任形象,荣获“2021年度公益集体奖”荣誉称号,公司“爱肝一生计划(项目)”荣获“2021年度公益项目奖”。","serverTime":1715916868078,"listedPrice":28.98,"stockholders":"14495人(较上一季度减少4.13%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"福瑞股份(300049)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供福瑞股份(300049)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"福瑞股份,300049,福瑞股份股票,福瑞股份股票老虎,福瑞股份股票老虎国际,福瑞股份行情,福瑞股份股票行情,福瑞股份股价,福瑞股份股市,福瑞股份股票价格,福瑞股份股票交易,福瑞股份股票购买,福瑞股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"福瑞股份(300049)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供福瑞股份(300049)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}